-
Raw Materials |Active Pharmaceutical Ingredient Intermedia |Diabetes |(R) -3-(Boc-Amino)piperidine |CAS:309956-78-3 |C10H20N2O2
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Active Pharmaceutical Ingredient Intermedia |Diabetes |(R) -3-(Boc-Amino)piperidine |CAS:309956-78-3 |C10H20N2O2
-
Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Amino acid series |D-Lysine |CAS:923-27-3 |C6H14N2O2
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Amino acid series |D-Lysine |CAS:923-27-3 |C6H14N2O2
-
Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |N-alpha-Cbz-L-lysine |CAS No.:2212-75-1 |C34H42N2O6
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |N-alpha-Cbz-L-lysine |CAS No.:2212-75-1 |C34H42N2O6
-
Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |N-alpha-Cbz-L-lysine |CAS No.:204777-78-6
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |N-alpha-Cbz-L-lysine |CAS No.:204777-78-6 |C34H42N2O6
-
Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |ZD-LYS-OH |CAS No.:70671-54-4 |C14H20N2O4
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Immunology |Peptide synthesis |Natural Amino Acid |ZD-LYS-OH |CAS No.:70671-54-4 |C14H20N2O4
-
Pharmaceutical Intermedia Reagents |Rudis materiae |Oxirane, 2-(7Z,10Z)-7,10-hexadecadien-1-yl- |CAS No.:1883429-78-4
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |Oxirane, 2-(7Z,10Z)-7,10-hexadecadien-1-yl- |CAS No.:1883429-78-4 |C18H32O
-
Pharmaceutical Intermedia |Rudis materiae |BOC-(S)-HABA |CAS No.:207305-60-0 |C9H17NO5
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |BOC-(S)-HABA |CAS No.:207305-60-0 |C9H17NO5
-
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |Antibiotic |Tetracycline Intermedia|Sancycline hydrochloride |CAS:6625-20-3
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |Antibiotic |Tetracycline Intermedia|Sancycline hydrochloride |CAS:6625-20-3 |C21H23ClN2O7
-
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |Antibiotic |Tetracycline Intermedia|Minocycline hydrochloride |CAS:13614-98-7
Lorem vestibulum ac copia biopharmaceutical |Pharmaceutical Intermedia Reagents |Rudis materiae |Antibiotic |Tetracycline Intermedia|Minocycline hydrochloride |CAS:13614-98-7 |C23H28ClN3O7
-
Biopharmaceutical |Cardiovascular Diseases |L-Octahydroindole-2- carboxylicacidbenzylester 4- methylbenzenesulfonate |CAS:94062-52-9 |C16H21NO2.C7H8O3S
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Cardiovascular Diseases |High Blood Pressure |L-Octahydroindole-2- carboxylicacidbenzylester 4- methylbenzenesulfonate |CAS:94062-52-9 |C16H21NO2.C7H8O3S
-
Biopharmaceutical |Cardiovascular Diseases |2-Chloro-L-phenylalanine |CAS:103616-89-3
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Cardiovascular Diseases |High Blood Pressure |2-Chloro-L-phenylalanine |CAS:103616-89-3 |C9H10ClNO2
-
Raw Materials |Pharmaceutical Intermedia |Cardiovascular |Diseases |L-Norvaline ethyl ester hydrochloride |CAS:40918-51-2 |C7H16ClNO2
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Pharmaceutical Intermedia Reagents |Cardiovascular Diseases |High Blood Pressure |L-Norvaline ethyl ester hydrochloride |CAS:40918-51-2 |C7H16ClNO2